"With open enrollment behind us, policymakers have begun to shift their focus on the rising cost of health care in a significant way.... For ACA supporters, recent actions are a sign of how important other factors are to blame for the high cost of health care. The starkest example of this was the recent letter sent by high ranking House Democrats to the manufacturer of Sovaldi, asking them to justify the [$1,000 per pill] price of its Hepatitis C drug, causing Gilead's stock to take a significant dive on fears that policymakers or other stakeholders would intervene to limit the price of the costly drug."  MORE >>